NCT04328441View on ClinicalTrials.gov

Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

1,511

Participants

Timeline

Start Date

March 25, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
COVID-19
Interventions
DRUG

BCG Vaccine

Intracutaneously 0.1ml BCG vaccine, which accounts for 0.075mg of attenuated Mycobacterium bovis

DRUG

Placebo

Intracutaneously 0.1ml NaCl 0,9%

Trial Locations (9)

Unknown

Canisius Wilhelmina Ziekenhuis, Nijmegen

Radboud UMC, Nijmegen

Sint Maartenskliniek, Nijmegen

Jeroen Bosch ziekenhuis, 's-Hertogenbosch

Noordwest Ziekenhuisgroep locatie Alkmaar, Alkmaar

Leiden University Medical Center, Leiden

Erasmus Medical Center, Rotterdam

Hagaziekenhuis, The Hague

University Medical Center Utrecht, Utrecht

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

lead

UMC Utrecht

OTHER

NCT04328441 - Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine | Biotech Hunter | Biotech Hunter